(Updated - September 8, 2022 6:10 AM EDT)

Guggenheim analyst Seamus Fernandez initiates coverage on Albireo Pharma (NASDAQ: ALBO) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE